If Zanzalintinib (XL092) Isn't Approved by Blue Cross Blue Shield in Michigan: Clinical Trial Access & Formulary Alternatives
Quick Answer: Getting Zanzalintinib (XL092) Coverage in Michigan
Zanzalintinib (XL092) is investigational and not FDA-approved, so Blue Cross Blue Shield of Michigan typically won't cover it outside clinical trials. Your fastest path: 1) Check if you qualify for ongoing STELLAR trials at ClinicalTrials.gov, 2) Request expanded access